Generated by GPT-5-mini| Awa Coll-Seck | |
|---|---|
| Name | Awa Coll-Seck |
| Birth date | 1951 |
| Birth place | Dakar, Senegal |
| Nationality | Senegalese |
| Alma mater | Université Cheikh Anta Diop, Université René Descartes |
| Occupation | Physician, epidemiologist, politician |
| Known for | Vaccine development, public health leadership |
Awa Coll-Seck is a Senegalese physician, epidemiologist, and politician noted for her leadership in infectious disease control, vaccine research, and global health policy. She has served in ministerial roles in Senegal and in senior positions with international organizations, contributing to initiatives on malaria, HIV/AIDS, immunization, and pandemic preparedness. Her career bridges clinical medicine, academic research, and multilateral diplomacy.
Born in Dakar, Coll-Seck studied medicine at Université Cheikh Anta Diop and trained in parasitology at Institut Pasteur affiliates before completing doctoral studies at Université René Descartes (Paris V). She pursued postgraduate work in immunology and epidemiology at institutions linked to World Health Organization collaborations and engaged with research networks connected to Institut Pasteur de Dakar, Harvard T.H. Chan School of Public Health, and University of Oxford. Her early mentors and collaborators included faculty from Université Paris Descartes, researchers associated with Institut de Recherche pour le Développement, and clinicians from Hôpital Necker–Enfants Malades. She later held visiting appointments and collaborative roles with laboratories tied to Centers for Disease Control and Prevention, London School of Hygiene & Tropical Medicine, and University of Geneva.
Coll-Seck's research focused on malaria, schistosomiasis, and HIV, leading collaborations with scientists at Institut Pasteur, Wellcome Trust, Pasteur–Paris University (PPU) International Network, and the European & Developing Countries Clinical Trials Partnership. She contributed to vaccine development efforts alongside teams at Gavi, the Vaccine Alliance, PATH, International Vaccine Institute, and Bill & Melinda Gates Foundation–funded programs. Her publications intersected with scholars from Johns Hopkins Bloomberg School of Public Health, Institut Rockfeller de Paris, and Karolinska Institutet, and she participated in multicenter trials coordinated with WHO Malaria Vaccine Implementation Programme, Medicines for Malaria Venture, and Bill & Melinda Gates Foundation-funded Malaria Vaccine Initiative. Coll-Seck also collaborated with researchers affiliated with Institut Pasteur de Lille, University of Cambridge, Imperial College London, and McGill University on epidemiological surveillance and translational research. Her laboratory and fieldwork coordinated with public health authorities such as Ministry of Health (Senegal), provincial health departments, and regional offices of the World Health Organization Regional Office for Africa.
She served twice as Senegal's Minister of Health and Prevention and as Minister of State, operating within administrations that engaged with regional bodies including the Economic Community of West African States and the African Union. In government she worked with counterparts from France, United Kingdom, United States, Germany, and Norway on bilateral health initiatives and signed agreements with agencies like United Nations Children's Fund, United Nations Development Programme, and World Bank. Coll-Seck participated in summits such as the African Union Summit, the Tokyo International Conference on African Development, and the Summit of the Future-style forums, coordinating with leaders from Nigeria, Ghana, South Africa, Rwanda, and Ethiopia. Her ministerial tenure involved interactions with institutions including African Development Bank, Global Fund to Fight AIDS, Tuberculosis and Malaria, and United Nations General Assembly health sessions.
At the international level Coll-Seck served as Executive Director of the Roll Back Malaria Partnership and as a member of advisory boards for Gavi, the Vaccine Alliance, UNICEF, and the World Health Organization. She engaged with global initiatives like the Global Fund, the Global Polio Eradication Initiative, and the Stop TB Partnership, collaborating with leaders from UNAIDS, UNICEF, WHO Director-General offices, and research consortia including Coalition for Epidemic Preparedness Innovations and CEPI. Coll-Seck contributed to policy dialogues at World Economic Forum meetings, United Nations General Assembly High-Level Meetings on health, and the International Conference on AIDS and STIs in Africa. She has been part of expert panels convened by Harvard Global Health Institute, Chatham House, Africa Centres for Disease Control and Prevention, and European Centre for Disease Prevention and Control on topics of immunization strategy, vaccine equity, and pandemic preparedness. Her work interfaced with philanthropic partners such as Rockefeller Foundation and Ford Foundation and with multilateral research funders like National Institutes of Health and European Commission Horizon 2020 programs.
Coll-Seck has received national and international honors from institutions including the Government of Senegal, the French Government decorations conferred by Ordre national du Mérite and interactions with Académie Nationale de Médecine (France)]. She has been recognized by academic bodies such as Academy of Sciences of Senegal, Royal Society of Tropical Medicine and Hygiene, and invited to lecture at Massachusetts Institute of Technology, Yale School of Public Health, Columbia University, and Princeton University. International acknowledgments include awards and fellowships associated with World Health Organization, Bill & Melinda Gates Foundation, Council on Foreign Relations, Africa Progress Panel, and memberships in networks connected to Global Health Council and International Society for Infectious Diseases.
Coll-Seck's legacy is reflected in strengthened public health institutions across Senegal, expanded vaccine access initiatives involving Gavi, and sustained partnerships among WHO, UNICEF, and African public health agencies. Her mentorship influenced researchers and policymakers affiliated with Université Cheikh Anta Diop, Institut Pasteur de Dakar, African Union Commission, and regional training programs supported by Africa CDC and West African Health Organization. She has engaged with civil society organizations such as Médecins Sans Frontières, PATH, and Clinton Health Access Initiative in advocacy for equitable health interventions. Her career continues to be cited in policy reports from World Bank, United Nations, African Development Bank, and think tanks like Brookings Institution and Chatham House as foundational to modern African public health leadership.
Category:Senegalese physicians Category:Public health officials